Advanced in Hyperparathyroidism

Suetonia C. Palmer

2 Riccarton Ave, 
Christchurch, CAN, NZ 
Clinical Trials:Currently Recruiting for 1 Trial
Advanced in Hyperparathyroidism
2 Riccarton Ave, 
Christchurch, CAN, NZ 
OverviewLocationsClinical Research

Overview

Suetonia Palmer practices in Christchurch, New Zealand. Palmer is rated as an Advanced expert by MediFind in the treatment of Hyperparathyroidism. Their top areas of expertise are Chronic Kidney Disease, End-Stage Renal Disease (ESRD), High Potassium Level, Kidney Transplant, and Parathyroidectomy.

Their clinical research consists of co-authoring 215 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 8 articles in the study of Hyperparathyroidism.

Locations

2 Riccarton Ave, Christchurch, CAN 8140, New Zealand

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

An Investigator-initiated, International, Multi-centre, Prospective, Randomized, Open-label, Parallel-group, Superiority, and Pragmatic Large Simple Trial (LST) to Determine Whether the Currently Recommended Strategy of Intensive Reduction of Serum Phosphate Concentration Towards the Normal Level Results in Significant Patient-centred Benefits in End-stage Kidney Disease (ESKD) Patients Receiving Dialysis.
An Investigator-initiated, International, Multi-centre, Prospective, Randomized, Open-label, Parallel-group, Superiority, and Pragmatic Large Simple Trial (LST) to Determine Whether the Currently Recommended Strategy of Intensive Reduction of Serum Phosphate Concentration Towards the Normal Level Results in Significant Patient-centred Benefits in End-stage Kidney Disease (ESKD) Patients Receiving Dialysis.
Enrollment Status: Recruiting
Publish Date: July 01, 2025
Intervention Type: Drug
Study Phase: Not Applicable

215 Total Publications

Nephrology Health Professionals' Perspectives on Their Preferred Modality for Scientific Meetings, Balancing Affordability, Sustainability and Opportunities to Interact With Peers: An International Society of Nephrology Survey.
Nephrology Health Professionals' Perspectives on Their Preferred Modality for Scientific Meetings, Balancing Affordability, Sustainability and Opportunities to Interact With Peers: An International Society of Nephrology Survey.
Journal: Kidney international reports
Published: October 08, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Palmer's expertise for a condition
ConditionClose
    View All 10 Advanced Conditions
    View All 27 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile